Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study

• Main Authors: Kriangkrai Tawinprai (Author), Pawornrath Jungsomsri (Author), Onnicha Pinijnai (Author), Fahsiri Tavonvunchai (Author), Anchisa Lievjaroen (Author), Paphada Suwannaroj (Author), Taweegrit Siripongboonsitti (Author), Thachanun Porntharukchareon (Author), Gaidganok Sornsamdang (Author), Teerapat Ungtrakul (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The global supply of COVID-19 vaccines has been limited, and concerns have arisen about vaccine supply chain disruptions in developing countries. Heterologous prime-boost vaccination, which involves using different vaccines for the first and second doses, has been proposed to enhance the immune resp...